Searching for new ways to block the growth of cancer cells is like looking for a needle in a haystack. Tumor cells rely on thousands of proteins to function, but only a few of those proteins can be precisely targeted by drugs to treat cancer safely and effectively. Now, a team at Scripps Research and the Broad Institute of Harvard and MIT has spearheaded a new method to home in on new drug targets most likely to impact multiple cancers.
Click here for original story, Precise genome engineering and protein activity profiling uncover new cancer drug targets
Source: Phys.org